| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-260 |
| PharmacoGx | KIN001-260 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JMY | GDSC1000 | pan-cancer | AAC | 0.081 | 0.009 |
| mRNA | STXBP3 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | SLC35D2 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | SLC25A21 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.009 |
| mRNA | TNFRSF9 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.009 |
| mRNA | TRAK2 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | TNFRSF12A | GDSC1000 | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | MYO1F | GDSC1000 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | UBXN7 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | KIF5A | GDSC1000 | pan-cancer | AAC | 0.088 | 0.009 |
